Designing Ten New Drug Candidates to Block HIV-1 Integrase: A Computational Study Targeting the Enzyme's Magnesium-Dependent Active Site
Human Immunodeficiency Virus type 1 (HIV-1) integrase is an essential enzyme that inserts viral DNA into human host cell genomes. Rising clinical resistance to established integrase strand transfer inhibitors (INSTIs) necessitates novel therapeutic strategies. Here, we designed ten de novo small-molecule inhibitors (NI...